cladribine has been researched along with Edema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cubitt, C; Komrokji, RS; Lancet, JE; List, AF; Mirza, AS; Nardelli, L; Padron, E; Pinilla-Ibarz, J; Sweet, K | 1 |
| Fukuda, T; Harada, M; Henzan, H; Hikiji, W; Mitsugi, K; Miyamoto, T; Nagafuji, K; Numata, A; Oribe, N; Shimoda, K; Takase, K; Tanimoto, TE | 1 |
1 trial(s) available for cladribine and Edema
| Article | Year |
|---|---|
A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Diarrhea; Drug Resistance, Neoplasm; Edema; Female; Granulocyte Colony-Stimulating Factor; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Leukemia, Myeloid; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Treatment Outcome | 2017 |
1 other study(ies) available for cladribine and Edema
| Article | Year |
|---|---|
Edema of the eyelids and sclera after rituximab infusion for orbital MALT lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cladribine; Combined Modality Therapy; Edema; Eye Neoplasms; Eyelid Diseases; Humans; Infusions, Intravenous; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Rituximab | 2004 |